Grant: Discovery Grants Program - Individual
Université de Montréal
$36,000.00
Molecular mechanisms governing the lysosomal pathway of apoptosis
EF 2013-14
Résumé
A lysosomal pathway characterized by partial rupture of lysosomal membranes, referred as lysosome labilization is evoked during the early events of apoptosis in human cells. In comparative proteomics analyses performed on highly-enriched lysosomes, we identified proteins whose translocation to lysosomes correlated with lysosome labilization, including protein kinase C-delta (PKC-d), prosaposin (PSAP) and sterol-4-alpha-carboxylate 3-dehydrogenase (NSDHL), and whose functions are associated with lysosomal membrane fluidity and dynamics. PKC-d translocation to lysosomes is associated with lysosomal acidic sphingomyelinase (ASM) phosphorylation and activation, which in turn leads to an increase of ceramide (CER) content at lysosomes. In addition, we also observed apparent lysophosphatidylcholine (LPC) accumulation suggesting a cooperation between CER and LPC in lysosomes, most likely at specific lipid microdomains known as lipid rafts. The goal of our research program is to understand the molecular mechanisms responsible for lysosome labilization in apoptosis. Our hypothesis is that PKC-d, PSAP and NSDHL participate in activating key enzymes of the lysophosphatidylcholine and sphingolipid pathways. In turn, these key enzymes modulate lysosomal membrane lysophosphatidyl-choline and ceramide content, most likely at specific lipid microdomains known as lipid rafts, triggering lysosome labilization and cathepsin release/activation during the early phase of apoptosis. To explore these hypothesis, we propose the following specific aims: Aim 1- To elaborate on the effects of PKC-d, PSAP and NSDHL on activating key lysosomal enzymes involved with lysophosphatidylcholine and sphingolipid metabolisms in cells udergoing lysosome labilization.Aim 2- To correlate activation of lysophosphatidylcholine- and sphingolipid-associated key enzymes with lysosome labilization, by evaluating the effects of silencing these enzymes by RNAi. Aim 3- To elaborate on the mechanisms by which specific lipid species, particularly lysophosphastidylcholine and ceramide, provoke lysosome labilization.
Programme
Discovery Grants Program - Individual
Bénéficiaire
Emplacement
Quebec, Canada
Type de bénéficiaire
Academia
Type
Grant
Source
NSERC's Awards Data
Tel que publié
Application id
328207-2011
Name nom
Bertrand, Richard
Department département
Médecine
Organization id
63
Institution établissement
Université de Montréal
Province en
Québec
Province fr
Québec
Country en
CANADA
Country fr
CANADA
Fiscal year exercice financier
2013
Competition year année de concours
2011
Award amount
36000
Program id
RGPIN
Program name en
Discovery Grants Program - Individual
Program name fr
Programme de subventions à la découverte - individuelles
Group en
Discovery grants programs
Group fr
Programmes de subventions à la découverte
Committee code
1501
Committee name en
Genes, Cells and Molecules
Committee name fr
Gènes, cellules et molécules
Area of application code
1200
Area of application group en
Advancement of knowledge
Area of application group fr
Avancement des connaissances
Area of application en
Advancement of knowledge
Area of application fr
Avancement des connaissances
Research subject code
5100
Research subject group en
Cell biology
Research subject group fr
Biologie cellulaire
Research subject en
Cell biology
Research subject fr
Biologie cellulaire
Partie
3
Nb partie
5
Application title
Molecular mechanisms governing the lysosomal pathway of apoptosis
Keyword
NSERC
Application summary
A lysosomal pathway characterized by partial rupture of lysosomal membranes, referred as lysosome labilization is evoked during the early events of apoptosis in human cells. In comparative proteomics analyses performed on highly-enriched lysosomes, we identified proteins whose translocation to lysosomes correlated with lysosome labilization, including protein kinase C-delta (PKC-d), prosaposin (PSAP) and sterol-4-alpha-carboxylate 3-dehydrogenase (NSDHL), and whose functions are associated with lysosomal membrane fluidity and dynamics. PKC-d translocation to lysosomes is associated with lysosomal acidic sphingomyelinase (ASM) phosphorylation and activation, which in turn leads to an increase of ceramide (CER) content at lysosomes. In addition, we also observed apparent lysophosphatidylcholine (LPC) accumulation suggesting a cooperation between CER and LPC in lysosomes, most likely at specific lipid microdomains known as lipid rafts. The goal of our research program is to understand the molecular mechanisms responsible for lysosome labilization in apoptosis. Our hypothesis is that PKC-d, PSAP and NSDHL participate in activating key enzymes of the lysophosphatidylcholine and sphingolipid pathways. In turn, these key enzymes modulate lysosomal membrane lysophosphatidyl-choline and ceramide content, most likely at specific lipid microdomains known as lipid rafts, triggering lysosome labilization and cathepsin release/activation during the early phase of apoptosis. To explore these hypothesis, we propose the following specific aims: Aim 1- To elaborate on the effects of PKC-d, PSAP and NSDHL on activating key lysosomal enzymes involved with lysophosphatidylcholine and sphingolipid metabolisms in cells udergoing lysosome labilization.Aim 2- To correlate activation of lysophosphatidylcholine- and sphingolipid-associated key enzymes with lysosome labilization, by evaluating the effects of silencing these enzymes by RNAi. Aim 3- To elaborate on the mechanisms by which specific lipid species, particularly lysophosphastidylcholine and ceramide, provoke lysosome labilization.